Invention Grant
US08507560B2 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
有权
包含具有甲酰肽受体1（FPRL-1）激动剂或拮抗剂活性的3,4-二氢异喹啉-2（1H） - 基-3-苯基脲衍生物的药物组合物
- Patent Title: Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
- Patent Title (中): 包含具有甲酰肽受体1（FPRL-1）激动剂或拮抗剂活性的3,4-二氢异喹啉-2（1H） - 基-3-苯基脲衍生物的药物组合物
-
Application No.: US13300729Application Date: 2011-11-21
-
Publication No.: US08507560B2Publication Date: 2013-08-13
- Inventor: Richard L. Beard , John E. Donello , Michael E. Garst , Veena Viswanath
- Applicant: Richard L. Beard , John E. Donello , Michael E. Garst , Veena Viswanath
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A01N47/28
- IPC: A01N47/28 ; A61K31/17 ; A61K31/47 ; A01N43/42 ; C07D217/02 ; C07C273/00 ; C07C275/00
Abstract:
The present invention relates to a method of treating a disorder associated with modulation of the FPRL-1 receptor which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising a 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivative.
Public/Granted literature
Information query
IPC分类:
